MultiomeDx (previously KAYA17)

📍 Livermore, United States👥 6 employees💰 Last funded Oct 2020
Biotechnology🌐 multiomedx.com
Website LinkedIn
MultiomeDx is focused on Women’s Health Diagnostics. We are providing Point-of-Care solution for various unmet needs in women’s Diagnostics. Our first product is a rule out test for Pre-eclampsia. We are also focused on deploying our point of care tests to hard to reach areas in India for cervical cancer screening. Since the platform, POC device is sensitive, accurate and cost effective, it is a great fit for deploying in a mobile van to hard to reach areas. The same platform can also test for other tropical diseases such as Dengue and Chikungunya.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in MultiomeDx (previously KAYA17)?
MultiomeDx (previously KAYA17) has 1 investors on record on gritt.io.
When did MultiomeDx (previously KAYA17) last raise funding?
The most recent investment in MultiomeDx (previously KAYA17) recorded on gritt.io was in October 2020.
What industry is MultiomeDx (previously KAYA17) in?
MultiomeDx (previously KAYA17) operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is MultiomeDx (previously KAYA17) based?
MultiomeDx (previously KAYA17) is headquartered in Livermore, United States.